heXem bio
HexemBio develops a synthetic human Yolk Sac platform to rejuvenate blood stem cells to extend healthy lifespan.
$2M Seed ·
Led by Draper Associates · Source: einpresswire.com
All 2 rounds ↓Signals
Website registeredMay 28, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $2M | einpresswire.com |
Timeline
- Website created
- IndieBio NY 09
IIndieBio · batchSource: indiebio.co
Founders and team
SY
Samet Yildirim Founder
Investors
BBoost VCaccelerator
DDraper Associateslead investor
EEmerald Development Managers
FFelipe Sierra
HHappiness Capital
IIndieBioaccelerator- JJoanne Kurtzberg
KKorea Investment Partners
SSeraphim Space
SSOSV
Companies like heXem bio
SSyntax$14.4M · Jun 2026AAnja HealthSeed · Nov 2024
LLoyalSeries B+ · Mar 2026
BBig Bold HealthSeries B+ · Jan 2025
EEeum BioSeed · Sep 2026
IInspecity$10.4M Seed · Aug 2026
Other companies backed by Draper Associates
GGama$16.62M · Nov 2026
AAIsa$9M Seed · Oct 2026
Mmogul club$15.5M Series A · Oct 2026
AAvarra$17M Series A · Oct 2026
PPrecision Neuroscience$250M Series B+ · Sep 2026
CCloverleaf Bio$33M Seed · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/hexem-bio (get a free API key).